92.89MMarket Cap
LossP/E TTM
Aldeyra Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Aldeyra Therapeutics Inc is 6.20, ranking 328 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.38, which is -56.69% below the recent high of -1.47 and -237.93% above the recent low of -11.44.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.